Today's Law As Amended

PDF |Add To My Favorites |Track Bill | print page

AB-11 Early and Periodic Screening, Diagnosis, and Treatment Program: screening services.(2017-2018)



SECTION 1.
 The Legislature finds and declares all of the following:
(a) Not all children experience a clear path toward healthy development, making the early identification of developmental concerns and the timely connection to appropriate intervention essential to a child’s well-being.
(b) Despite the prevalence of developmental delays and disorders, the overall rate of developmental screening remains low and the use of validated screening tools is often inconsistent.
(c) Many children at risk for developmental delays or disabilities due to environmental or biological factors are not identified in a timely fashion, greatly reducing the effectiveness of applied intervention.
(d) The Bright Futures Guidelines by the American Academy of Pediatrics provide evidence-driven guidance for all preventive care screenings and well-child visits, recommending that developmental surveillance include the periodic administration of a standardized developmental screening test.
(e) Early access to appropriate intervention for children with developmental delays and disabilities is critically important for healthy and optimal development.

SEC. 2.

 Section 14132.195 is added to the Welfare and Institutions Code, immediately following Section 14132.19, to read:

14132.195.
 Consistent with federal law, screening services provided under the Early and Periodic Screening, Diagnosis, and Treatment (EPSDT) benefit pursuant to subdivision (v) of Section 14132 shall include developmental screening services for individuals zero to three years of age, inclusive.

SEC. 3.

 Section 14197.07 is added to the Welfare and Institutions Code, to read:

14197.07.
 (a) As part of the federally required external quality review organization (EQRO) review of Medi-Cal managed care plans in the annual detailed technical report required by Section 438.364 of Title 42 of the Code of Federal Regulations, effective for contract periods commencing on or after July 1, 2018, the EQRO entity shall annually review, survey, and report on managed care plan reporting and compliance with the use of the validated developmental screening tools and periodicity schedule recommended by the American Academy of Pediatrics for children zero to three years of age, inclusive.
(b) This section shall remain in effect only until July 1, 2023, and as of that date is repealed.